PATENT CLAIM ANALYSIS

Application Number: 16159135
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["435", "136000"]

Abstract:
This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a chemical product, which includes 3-hydroxypropionic acid.

Claim (Index 9):
The method of  claim 8 , wherein said heterologous nucleic acid sequence is a sequence having at least 90% homology with SEQ ID NO. 337.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 97.0
- Lexical Diversity: 1.16667
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14575927', '15167439', '13916534', '13498468', '15317768']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.727125856015471
- 35 USC 102 Novelty (BERT): 0.6747225247731026
- Combined Prediction Score: 0.7218855228912342
- Mean Citation Score: 625.6340739999998
- Max Citation Score: 696.5435
- Similarity Product: 669.7707004240751

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test